Genomic predictors and oncogenic drivers in hepatocellular carcinoma.
will optimise decision-making for liver cancer patients by identifying genomic prognostic determinants and oncogenic drivers.
core team comprises leading European researchers in the basic, translational and clinical fields of liver cancer.
is a 3-year translational research project which aims to solve core problems in the management of hepatocellular carcinoma (HCC), the third most common cause of cancer-related death worldwide.
Five researchers from IDIBAPS among the most cited scientists
Thomson Reuters has published the list of the Highly Cited Researchers, a compilation of the most influential names in science. 50 Spanish researchers from different broad fields of sciences and social sciences appear on the list. In the field of Clinical Medicine, four of the seven Spanish investigators listed are researchers from IDIBAPS. The health research institute associated to Hospital Clínic and Universitat de Barcelona also has the only Spanish researcher in Psychiatry.
These five IDIBAPS investigators are Dr. Joan Bladé, from the Hematology Service (ICMHO) and member of the IDIBAPS teamHematological Oncology; Dr. Jordi Bruix, Head of the Barcelona Clinic Liver Cancer (BCLC) and head of the Hepatic Oncologygroup at IDIBAPS; Dr. Elias Campo, Research Director of Hospital Clínic and Fundació Clínic and head of the Human and Experimental Functional oncomorphology IDIBAPS Group; Dr. Josep Maria Llovet, ICREA Research Professor at the HCC Translational Research Lab of the Liver Unit at IDIBAPS and Director of Mount Sinai Liver Cancer Program at the Icahn School of Medicine at Mount Sinai (New York); and Dr. Eduard Vieta, head of Psychiatry and Psychology and leader of the Bipolar Disorders team at IDIBAPS.
Thomson Reuters lists the 3000 most important names of 21 fields in science and social sciences. There have been evaluated articles published in indexed journals in these fields between 2002 and 2012 and there have only been considered those that rank in the top 1% by citations for field and year indexed in the Web of Science, the so called Highly Cited Papers. Thus, the fact of belonging to this classification means that the work of these researchers is considered particularly important among his colleagues.
Prof Josep M Llovet
Xu MZ, Chan SW, Liu AM, Wong KF, Fan ST, Chen J, Poon RT, Zender L, Lowe SW, Hong W, Luk JM.
Berdasco M, Esteller M.
Gaujoux S, Pinson S, Gimenez-Roqueplo AP, Amar L, Ragazzon B, Launay P, Meatchi T, Libé R, Bertagna X, Audebourg A, Zucman-Rossi J, Tissier F, Bertherat J.
More scientific publications
Prof. Vincenzo Mazzaferro
Fondazione IRCCS Istituto Nazionale dei tumori (INT)
Project led by:
Copyright © 2010 - 2014 HEPTROMIC
HEPTROMIC is a project in the 'Health' Theme of the Specific Programme 'Cooperation' of the European Commission's Seventh Framework Programme.